Bill proposes the cultivation of medical cannabis and industrial hemp in Brazil
Text wants to expand access to medicine and create yet another option for agribusiness in the country
Wednesday, August 19, 2020
The cannabis sector is heating up for a big start in Brazil. Deputy Paulo Teixeira (PT-SP) handed over the proposed law 399/2015, which legalizes the cultivation of cannabis in Brazil for medical and industrial use, to the president of the Chamber of Deputies. The proposal foresees an increase in plant-based medicine because it reduces the cost of imported input, lowering the price of cannabis drugs. "In pharmacies, there are two Cannabis-based medicines registered by Anvisa [Health Surveillance Agency], Sativex, produced by the English company GW Pharma, and Cannabidiol, by Brazilian Prati-Donaduzzi," says Teixeira. On average, each costs R $ 2,500. Prati's cannabidiol comes from Canada. (See also: Brazilian plan for legal cultivation of industrial hemp, MMJ moving ahead as nation battles pandemic)